Gradual shift towards cloud-based solutions along with availability of different patient-centric eClinical solutions including eCOA will spur the market growth. For instance, in March 2022, Kayentis launched a fully integrated patient-centric platform, streamlining the management of hybrid and DCT and overcoming logistical hurdles in patient-centric trial execution. The integrated solution aimed to streamline remote clinical trials, making them easier to manage for patients, sites, CROs, and sponsors, thus reducing patient burden and enhancing participation.
Similarly, in June 2021, Medidata introduced myMedidataRegistries, enhancing patient engagement throughout the clinical trial process and addressing critical needs in clinical development.
Thus, the growing advancement and approach towards novel methods over the traditional solutions intends to expand the market growth in the coming years.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The market size of electronic clinical outcome assessment solution reached USD 1.5 billion in 2023 and is set to cross USD 4.8 billion by 2032, due to the increasing emphasis on patient-centric healthcare and personalized medicine.
The web-hosted solutions deployment model segment held 47.8% of the market share in 2023, owing to their advantages, including user-friendly interfaces, easy accessibility, and lower investment needs.
North America market size is poised to witness 14.1% CAGR from 2024 to 2032, attributed to the ongoing development of healthcare infrastructure coupled with increased R&D activities leading to a surge in clinical trials.
Some of the prominent market players include AssisTek, Climedo Health GmbH, Clinical ink, CRF Health, EvidentIQ, ICON plc, IQVIA, Integra IT S.A.S, Kayentis, Medidata, and Oracle Corporation.